Persistence with treatment for hypertension in actual practice

CMAJ. Canadian Medical Association Journal

Volumn 160, Issue 1, 1999, Pages 31-37

  Caro, J Jaime ^a,b,d   Salas, Maribel ^a   Speckman, Jeanne L ^a   Raggio, Gabriel ^a   Jackson, Joseph D ^c  

^a CARO RESEARCH INSTITUTE   (United States)

^b ROYAL VICTORIA HOSPITAL   (Canada)

^c BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; TRIAMTERENE;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CANADA; DATA BASE; DIAGNOSIS; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRESCRIPTION; THERAPY;

EID: 0033547740     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. 1. Kannel WB. Blood pressure as a cardiovascular risk factor. JAMA 1996;275: 1571-6.
2. 2. Levy D, Larson MG, Vasan RS, Kannel W, Kalon K. The progression from hypertension to congestive heart failure. JAMA 1996;275:1557-62.
3. 3. Moser M. Historical perspective on the management of hypertension. Am J Med 1986;80:1-11.
4. 4. Gueyffier P, Froment A, Gouton M. New meta-analysis of treatment trials of hypertension: improving the estimate of benefit. J Hum Hypertens 1996;10:1-8.
5. 5. Neaton JD, Grimm RH, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, et al. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA 1993;270:713-24.
6. 6. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.
7. 7. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ 1985;291:97-104.
8. 8. Drugs for hypertension. Med Lett Drugs Ther 1995;37:45-50.
9. 9. Stockwell DH, Madhavan S, Cohen H, Gibson G, Alderman MH. The determinants of hypertension awareness, treatment and control in an insured population. Am J Public Health 1994;84:1768-74.
10. 10. Mancia G, Sega R, Milesi C, Cesana G, Zanchetti A. Blood pressure control in the hypertensive population. Lancet 1997;349:454-7.
11. 11. Joffres MR, Hamet P, Rabkin SW, Gelskey D, Hogan K, Fodor G. Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ 1992;146:1997-2005.
12. 12. Hershey JC, Morton BG, Davis JB, Reichgott MJ. Patient compliance with antihypertensive medication. Am J Public Health 1980;70:1081-9.
13. 13. Lücher TF, Vetter H, Siegenthaler W, Vetter W. Compliance in hypertension: facts and concepts. J Hypertens 1985;3:3-9.
14. 14. Bittar N. Maintaining long-term control of blood pressure: the role of improved compliance. Clin Cardiol 1995;18:312-6.
15. 15. Pablos-Méndez A, Barr G, Shea S. Run-in periods in randomized trials. JAMA 1998;279:222-5.
16. 16. Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ 1995;311:293-5.
17. 17. Hamilton RA, Briceland LL. Use of prescription-refill records to assess patient compliance. Am J Hosp Pharm 1992;49:1691-6.
18. 18. Elliott WJ. Discontinuation rates for ACE inhibitors and calcium antagonists in a tertiary hypertension clinic [abstract]. Am J Hypertens 1993;6:94A.
19. 19. Shea S, Misra D, Ehrlich MG, Field L, Francis CK. Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am J Public Health 1992;82:1607-12.
20. 20. Sharkness CM, Snow DA. The patient's view of hypertension and compliance. Am J Prev Med 1992;8:141-6.
21. 21. Cooper JK, Love DW, Raffoul PR. Intentional prescription nonadherence (noncompliance) by the elderly. J Am Geriatr Soc 1982;30:329-33.
22. 22. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens 1997;10(7 pt 1):697-704.
23. 23. Okano GL, Rascati KL, Wilson JP, Remond DD, Grabenstein JD, Brixner DI. Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker. Clin Ther 1997;19:1433-45.
24. 24. McAlister FA, Teo KK, Lewanczuk RZ, Wells G, Montague TJ. Contemporary practice patterns in the management of newly diagnosed hypertension. CMAJ 1997;157:23-30.
25. 25. Malcolm E, Downey W, Stand LM, McNutt M, West R. Saskatchewan Health's linkable data bases and pharmacoepidemiology. Post Mark Surveillance 1993;6:175-264.
26. 26. Annual statistical report 1994-1995. Regina: Saskatchewan Health Prescription Drug Services Branch. Government of Saskatchewan; 1996. p. 3.
27. 27. Brouch KL, Bowers CR, Aaron WS, editors. St Anthony's ICD9CM code book. Reston (VA): St Anthony Publishing; 1994.
28. 28. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley & Sons; 1980. p. 10-9.
29. 29. Tennis P, Bombardier C, Malcolm E, Downey W. Validity of rheumatoid arthritis diagnoses listed in the Saskatchewan Hospital Separations Database. J Clin Epidemiol 1993;46:675-83.
30. 30. Rawson NS, Malcolm E. Validity of the recording of ischaemic heart disease and chronic obstructive pulmonary disease in the Saskatchewan health care datafiles. Stat Med 1995;14:2627-43.
31. 31. Rawson NSB, Malcolm E, D'Arcy C. Reliability of the recording of schizophrenia and depressive disorder in the Saskatchewan health care datafiles. Soc Psychiatry Psychiatr Epidemiol 1997;32:191-9.
32. 32. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC-VI). Arch Intern Med 1997;157:2413-46.
33. 33. Reeves RA. Does this patient have hypertension? How to measure blood pressure. JAMA 1995;273:1211-8.
34. 34. Pierdomenico SD, Mezzetti A, Lapenna D, Guglielmi MD, Mancini M, Salvatore L, et al. "White-coat" hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care. Eur Heart J 1995;16:692-7.
35. 35. American Heart Association. 1998 heart and stroke statistical update. Dallas: The Association; 1997. p. 7.